The study findings also suggest approaches that enhance expression or activity of DMTF1 may have therapeutic potential in reversing or delaying aging-associated decline of neural stem cell function.
While the preliminary findings stemmed mainly from in vitro experiments, the researchers hope to explore if elevating DMTF1 expression can regenerate neural stem cell numbers as well as improve learning and memory under the conditions of telomere shortening and natural aging, without increasing the risk of brain tumors. The long-term objective is to discover small molecules that can enhance DMTF1 expression and activity to improve the function of aged neural stem cells.
“Our findings suggest that DMTF1 can contribute to neural stem cell multiplication in neurological aging,” Dr Liang said. “While our study is in its infancy, the findings provide a framework for understanding how aging-associated molecular changes affect neural stem cell behavior, and may ultimately guide the development of successful therapeutics.”








